Skip to content

Christopher Emig

Director at Gaius Therapeutics.

Earliest Form D on file: May 2026

Filed May 14, 2026

Gaius Therapeutics

Cell therapies for autoimmune disease

Biotech, San Diego CA

Named, Director.

$60K

sold of $250K offered

Form D

Network

At Gaius Therapeutics

5 people